The interaction of PD-1/PD-L1 via extracellular domains is a well-known immune checkpoint associated with the escape of cancer cells from immune-mediated destruction by inhibiting the anticancer effect of T cells [32]. The gene discussed is PDCD1; the disease is cancer.